Global Clamps Market: Restraints
The major restraining factor affecting the clamps market growth is product recalls by the U.S. Food and Drug Administration (FDA) due to improper functioning of clamps. For instance, in May 2018, the Extension line slide clamps from Arrow International Inc. was recalled by the U.S. FDA, as the product sterility was being compromised due to unsealed packaging of clamps. Sterilization is one of the important aspects of surgeries to avoid contamination. The use of unsterile and contaminated surgical instruments can possess great threats including acquired bacterial or viral infections such as hepatitis, AIDS, mad cow disease, etc.
Global Clamps Market: Drivers
The clamps market revenue is expected to increase over the forecast period, owing to increasing number of surgical procedures and rising demand for clamps and other surgical instruments. According to Healthcare Cost and Utilization Project (HCUP), in 2014, over 17.2 million hospital visits (ambulatory or inpatient) included invasive, therapeutic surgeries in the U.S. Over half of these visits (57.8 percent) occurred in a hospital-owned ambulatory surgery (AS) setting and the remaining (42.2 percent) were inpatient. Furthermore, the wide range of different types of clamps available such as bowel clamps, vascular clamps, bulldog clamps, etc. for different purposes in surgeries is also contributing to the clamps market growth.
Clamps Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients